Citigroup Inc Arcturus Therapeutics Holdings Inc. Transaction History

Citigroup Inc

$196 Billion
Q2 2025

A detailed history of Citigroup Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Citigroup Inc holds 16,588 shares of ARCT stock, worth $362,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,588

Previous 56,042 70.4%

Holding current value

$362,945

Previous $593,000 63.74%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$8.91 - $14.41 $351,535 - $568,532	-39,454 Reduced 70.4%	16,588 $215,000
Q1 2025 May 12, 2025	SELL	$10.59 - $20.83 $26,337 - $51,804	-2,487 Reduced 4.25%	56,042 $593,000
Q4 2024 Feb 12, 2025	BUY	$14.82 - $25.48 $576,705 - $991,528	38,914 Added 198.39%	58,529 $993,000
Q3 2024 Nov 12, 2024	BUY	$18.08 - $25.38 $84,614 - $118,778	4,680 Added 31.34%	19,615 $455,000
Q2 2024 Aug 12, 2024	SELL	$24.35 - $44.39 $2.96 Million - $5.39 Million	-121,472 Reduced 89.05%	14,935 $363,000
Q1 2024 May 10, 2024	BUY	$31.23 - $42.99 $2.73 Million - $3.76 Million	87,535 Added 179.11%	136,407 $4.61 Million
Q4 2023 Feb 09, 2024	SELL	$17.71 - $32.97 $149,702 - $278,695	-8,453 Reduced 14.75%	48,872 $1.54 Million
Q3 2023 Nov 09, 2023	BUY	$25.44 - $37.35 $96,163 - $141,183	3,780 Added 7.06%	57,325 $1.46 Million
Q2 2023 Aug 10, 2023	SELL	$23.94 - $32.36 $1.88 Million - $2.54 Million	-78,546 Reduced 59.46%	53,545 $1.54 Million
Q1 2023 May 11, 2023	BUY	$14.72 - $23.97 $581,101 - $946,263	39,477 Added 42.63%	132,091 $3.17 Million
Q4 2022 Feb 09, 2023	SELL	$14.14 - $23.06 $1.14 Million - $1.86 Million	-80,512 Reduced 46.5%	92,614 $1.57 Million
Q3 2022 Nov 10, 2022	BUY	$13.05 - $22.13 $603,588 - $1.02 Million	46,252 Added 36.46%	173,126 $2.57 Million
Q2 2022 Aug 10, 2022	BUY	$12.26 - $31.17 $987,653 - $2.51 Million	80,559 Added 173.94%	126,874 $2 Million
Q1 2022 May 12, 2022	SELL	$17.64 - $39.57 $1.47 Million - $3.3 Million	-83,509 Reduced 64.32%	46,315 $1.25 Million
Q4 2021 Feb 10, 2022	BUY	$34.2 - $47.56 $2.23 Million - $3.1 Million	65,188 Added 100.85%	129,824 $4.81 Million
Q3 2021 Nov 10, 2021	BUY	$27.88 - $58.25 $1.8 Million - $3.77 Million	64,636 New	64,636 $3.09 Million

Others Institutions Holding ARCT

# of Institutions

171

Shares Held

25.9M

Call Options Held

321K

Put Options Held

136K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $581M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account